Edition:
United Kingdom

Zeria Pharmaceutical Co Ltd (4559.T)

4559.T on Tokyo Stock Exchange

2,102JPY
24 Nov 2017
Change (% chg)

¥-19 (-0.90%)
Prev Close
¥2,121
Open
¥2,115
Day's High
¥2,115
Day's Low
¥2,094
Volume
59,500
Avg. Vol
133,459
52-wk High
¥2,197
52-wk Low
¥1,621

Latest Key Developments (Source: Significant Developments)

Zeria Pharmaceutical says extension of share repurchase period
Thursday, 2 Nov 2017 

Nov 2(Reuters) - Zeria Pharmaceutical Co Ltd <4559.T>:Says it extends share repurchase period to a deadline of Feb. 6, 2018, instead of Nov. 2 previously .Says share repurchase plan was announced on June 16 and revised on Aug. 4.  Full Article

Zeria Pharmaceutical to repurchase 6.8 pct shares
Friday, 4 Aug 2017 

Aug 4 (Reuters) - Zeria Pharmaceutical Co Ltd <4559.T>:Says it plans to repurchase up to 3.6 million shares, representing 6.8 percent of outstanding.Says share repurchase price at up to 7.2 billion yen in total.Says repurchase period from June 19 to Nov. 2.Previous news was disclosed on June 16.  Full Article

Zeria Pharmaceutical gets manufacture and marketing approval for Zentacort® Capsules 3mg
Wednesday, 28 Sep 2016 

Zeria Pharmaceutical Co Ltd <4559.T> :Says it gets manufacture and marketing approval for Zentacort® Capsules 3mg (Budesonide), as treatment for Crohn's disease.  Full Article

BRIEF-Zeria Pharmaceutical says extension of share repurchase period

* Says it extends share repurchase period to a deadline of Feb. 6, 2018, instead of Nov. 2 previously